HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

pagimaximab

recognizes lipoteichoic acid; has completed a Phase II study
Also Known As:
BSYX-A110
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results